Abstract
Currently available drugs against Trypanosoma cruzi infection, which causes 12000 deaths annually, have limitations in their efficacy, safety and tolerability. The evaluation of therapeutic responses to available and new compounds is based on parasite detection in the bloodstream but remains challenging because a substantial proportion of infected individuals have undetectable parasitemia even when using diagnostic tools with the highest accuracy. We characterize parasite dynamics which might impact drug efficacy assessments in chronic Chagas by analyzing pre- and post-treatment quantitative-PCR data obtained from blood samples collected regularly over a year. We show that parasitemia remains at a steady-state independently of the diagnostic sensitivity. This steady-state can be probabilistically quantified and robustly predicted at an individual level. Furthermore, individuals can be assigned to categories with distinct parasitological status, allowing a more detailed evaluation of the efficacy outcomes and adjustment for potential biases. Our analysis improves understanding of parasite dynamics and provides a novel background for optimizing future drug efficacy trials in Chagas disease.
Trial Registration: original trial registered with ClinicalTrials.gov, number NCT01489228.
Funder
Fundación Ramón Areces
Burroughs Wellcome Fund
Instituto de Salud Carlos III
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference29 articles.
1. Chagas disease;JA Pérez-Molina;Lancet,2018
2. An unfolding tragedy of Chagas disease in North America.;PJ Hotez;PLoS Negl Trop Dis,2013
3. Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis;A Requena-Méndez;PLoS Negl Trop Dis,2015
4. Estimating the Burden of Chagas Disease in the United States;J Manne-Goehler;PLoS Negl Trop Dis.,2016
5. Trypanocidal treatment of Chagas disease;JA Pérez-Molina;Enferm Infecc Microbiol Clin,2020
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献